
Evaluating progesterone receptor agonist megestrol plus letrozole for women with early-stage estrogen-receptor-positive breast cancer: the window-of-opportunity, randomized, phase 2b, PIONEER trial
<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE55Zk5jQ19Va3dHbGRGVEg0WVRqaUl2QW9IS2NHdUFnTGJJbS0tdW9TVTBGU3FWZXgxNWJodVVWanFfYmdTMi1GYzMxVmVaanNXOEkzMzVSQmZycE9TUDNV?oc=5" target="_blank">Evaluating progesterone receptor agonist megestrol plus letrozole for women with early-stage estrogen-receptor-positive breast cancer: the window-of-opportunity, randomized, phase 2b, PIONEER trial</a>&nbsp;&nbsp;<font color="#6f6f6f">Nature</font>
